XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population

Global cancer statistics

2011 • 55,498 citations

Global Cancer Statistics, 2002

2005 • 17,966 citations

Revisions in the International System for Staging Lung Cancer

1997 • 4,582 citations

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

1995 • 2,804 citations

Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials

1996 • 2,541 citations

Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan

2004 • 941 citations

Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.

2000 • 780 citations

A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage

2003 • 621 citations

XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.

1999 • 575 citations

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

1998 • 430 citations

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer

2005 • 415 citations

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

2001 • 302 citations

XPD and XRCC1 Genetic Polymorphisms Are Prognostic Factors in Advanced Non—Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy

2004 • 296 citations

Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer

2004 • 293 citations

Polymorphisms In The DNA Repair Gene Xrcc1 And Breast Cancer

2001 • 235 citations

Small Cell Lung Cancer*

2003 • 219 citations

Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.

2002 • 185 citations

Large-Scale Investigation of Base Excision Repair Genetic Polymorphisms and Lung Cancer Risk in a Multicenter Study

2005 • 185 citations

DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population

2002 • 179 citations

A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer.

2001 • 175 citations

DNA repair and cisplatin resistance in non-small-cell lung cancer

2002 • 171 citations

Polymorphisms in DNA Base Excision Repair Genes ADPRT and XRCC1 and Risk of Lung Cancer

2005 • 171 citations

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

2006 • 170 citations

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene

2004 • 169 citations

Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1.

2003 • 153 citations

DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer

2004 • 128 citations

Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population

2002 • 122 citations

Genetic polymorphisms of XRCC1 and risk of gastric cancer

2002 • 99 citations

Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

2005 • 85 citations

A prospective study of XRCC1(X-ray cross-complementing group 1) polymorphisms and breast cancer risk

2005 • 61 citations

Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer

2006 • 44 citations

[Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer].

2004 • 39 citations